← FDA Drug Approvals (Drugs@FDA)

IMAGENT

NDA · New Drug Application · Sponsor: VESSELON SPV LLC · Approved 2002-05-31

Drug application

FDA Application #

NDA021191

Application type

New Drug Application

Brand name

IMAGENT

Generic name

Dimyristoyl Lecithin

Active ingredients

DIMYRISTOYL LECITHIN; PERFLEXANE

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

VESSELON SPV LLC

First approval

2002-05-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown